EP Patent

EP2469281A1 — Method for managing the risk of liver injury in patients receiving treatment with dronedarone

Assigned to Sanofi SA · Expires 2012-06-27 · 14y expired

What this patent protects

The present invention concerns a method of managing the risk of liver injury in patients receiving treatment with dronedarone or pharmaceutically acceptable salts thereof.

USPTO Abstract

The present invention concerns a method of managing the risk of liver injury in patients receiving treatment with dronedarone or pharmaceutically acceptable salts thereof.

Drugs covered by this patent

dronedarone-hydrochloride (DRONEDARONE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2469281A1
Jurisdiction: EP
Classification: —
Expires: 2012-06-27
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.